- Home
- PRME vs CNC Comparison
PRME vs CNC Comparison
Compare PRME & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- CNC
- Stock Information
- Founded
- PRME 2019
- CNC 1984
- Country
- PRME United States
- CNC United States
- Employees
- PRME N/A
- CNC N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- CNC Medical Specialities
- Sector
- PRME Health Care
- CNC Health Care
- Exchange
- PRME Nasdaq
- CNC Nasdaq
- Market Cap
- PRME 191.7M
- CNC 28.1B
- IPO Year
- PRME 2022
- CNC 2001
- Fundamental
- Price
- PRME $4.27
- CNC $31.42
- Analyst Decision
- PRME Buy
- CNC Buy
- Analyst Count
- PRME 6
- CNC 17
- Target Price
- PRME $9.38
- CNC $64.75
- AVG Volume (30 Days)
- PRME 5.1M
- CNC 14.8M
- Earning Date
- PRME 08-04-2025
- CNC 07-25-2025
- Dividend Yield
- PRME N/A
- CNC N/A
- EPS Growth
- PRME N/A
- CNC 33.19
- EPS
- PRME N/A
- CNC 6.72
- Revenue
- PRME $3,846,000.00
- CNC $153,266,000,000.00
- Revenue This Year
- PRME $104.12
- CNC $23.63
- Revenue Next Year
- PRME $108.24
- CNC $0.61
- P/E Ratio
- PRME N/A
- CNC $4.68
- Revenue Growth
- PRME 550.76
- CNC 7.22
- 52 Week Low
- PRME $1.11
- CNC $31.40
- 52 Week High
- PRME $6.75
- CNC $80.59
- Technical
- Relative Strength Index (RSI)
- PRME 80.29
- CNC 15.73
- Support Level
- PRME $2.28
- CNC $31.78
- Resistance Level
- PRME $4.83
- CNC $33.41
- Average True Range (ATR)
- PRME 0.46
- CNC 1.52
- MACD
- PRME 0.21
- CNC -1.94
- Stochastic Oscillator
- PRME 84.52
- CNC 0.06
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.